Mednax Net Income From Continuing Ops Over Time
| MD Stock | USD 21.44 0.06 0.28% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Mednax Performance and Mednax Correlation. Will Health Care Providers & Services sector continue expanding? Could Mednax diversify its offerings? Factors like these will boost the valuation of Mednax. Expected growth trajectory for Mednax significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mednax data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 2.652 | Earnings Share 1.95 | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets |
Understanding Mednax Inc requires distinguishing between market price and book value, where the latter reflects Mednax's accounting equity. The concept of intrinsic value—what Mednax's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Mednax's price substantially above or below its fundamental value.
Understanding that Mednax's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mednax represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Mednax's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Net Income From Continuing Ops Analysis
Compare Mednax Inc and related stocks such as National HealthCare, Select Medical Holdings, and Acadia Healthcare Net Income From Continuing Ops Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NHC | 53.4 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | 53.1 M | 50.5 M | 60.6 M | 57.6 M | 55.7 M | 66 M | 152.9 M | 20 M | 65.3 M | 102.1 M | 117.4 M | 73.7 M |
| SEM | 112.8 M | 112.8 M | 153.9 M | 123 M | 128.2 M | 280.9 M | 125.3 M | 184.3 M | 294.2 M | 201 M | 344.6 M | 499.9 M | 198 M | 299.7 M | 130 M | 149.5 M | 241.7 M |
| ACHC | (32.9 M) | (32.9 M) | 20.5 M | 43.3 M | 83.2 M | 111.4 M | 4.2 M | 199.6 M | (175.5 M) | 110.1 M | 143.2 M | 208.2 M | 280 M | (12.3 M) | 264.5 M | 304.2 M | 319.4 M |
| ASTH | (720.3 K) | (720.3 K) | (8.9 M) | (4.6 M) | (1.3 M) | (8.2 M) | (8.7 M) | 45.8 M | 60.3 M | 17.7 M | 122.3 M | 49.3 M | 50.5 M | 57.8 M | 49.9 M | 57.4 M | 33.1 M |
| AVAH | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (47.1 M) | (76.5 M) | (57 M) | (117 M) | (662 M) | (346.6 M) | (10.9 M) | (9.8 M) | (10.3 M) |
| ARDT | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 244.6 M | 265.4 M | 122.9 M | 299.7 M | 344.7 M | 256.5 M |
| LFST | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | 5.7 M | (307.2 M) | (307.2 M) | (215.6 M) | (188 M) | (57.4 M) | (51.7 M) | (54.3 M) |
| GRDN | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 28.3 M | 49.7 M | 37.7 M | (71 M) | (63.9 M) | (60.7 M) |
| ADUS | (2 M) | (2 M) | 9.3 M | 11.2 M | 12 M | 11.4 M | 11.9 M | 13.5 M | 17.4 M | 25.8 M | 33.1 M | 45.1 M | 46 M | 57.7 M | 73.6 M | 84.6 M | 88.9 M |
| OGN | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 2.2 B | 3.2 B | 2.2 B | 1.4 B | 917 M | 585 M | 864 M | 777.6 M | 1.3 B |
Mednax Inc and related stocks such as National HealthCare, Select Medical Holdings, and Acadia Healthcare Net Income From Continuing Ops description
My Equities
My Current Equities and Potential Positions
| Mednax Inc | MD |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 1301 Concord Terrace, |
| Exchange | New York Stock Exchange |
USD 21.44
Check out Mednax Performance and Mednax Correlation. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Mednax technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.